Evidence map›Paper›PMID 33506310›Full record

ReviewMikrochimica acta2021

Recent advances in functionalization of plasmonic nanostructures for optical sensing.

Amirmostafa Amirjani, Erfan Rahbarimehr

Abstract readReview
PubMed Publisher
In one paragraph

Review in Mikrochimica acta, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. UV-light-responsive Ag/TiOScientific reports · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Amirmostafa AmirjaniMaterials Science and Engineering Department, Sharif University of Technology, P.O. Box 11155-9466, Azadi Avenue, Tehran, Iran. Amirjani@sharif.edu.ORCID 0000-0003-4345-1752
Erfan RahbarimehrDepartment of Chemistry, Université de Sherbrooke, QC, J1K 2R1, Canada.
Sharif University of Technology · IRUniversité de Sherbrooke · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review summarizes the progress that has been made in the use of nanostructured SPR-based chemical sensors and biosensors. Following an introduction into the field, a first large section covers principles of nanomaterial-based SPR sensing, mainly on methods using noble metal nanoparticles (spheres, cubes, triangular plates, etc.). The next section covers methods for functionalization of plasmonic nanostructures, with subsections on functionalization using (a) amino acids and proteins; (b) oligonucleotides, (c) organic polymers, and (d) organic compounds. Several tables are presented that give an overview on the wealth of methods and materials published. A concluding section summarizes the current status, addresses current challenges, and gives an outlook on potential future trends. This review is not intended to be a comprehensive compilation of the literature in the field but rather is a systematic overview of the state of the art in surface chemistry of plasmonic nanostructures. The ability of various ligands and receptors for functionalization of nanoparticles as well as their sensing capability is discussed.

Indexed as

Amino AcidsBacteriaHumansImmobilized Nucleic AcidsImmobilized ProteinsMetal NanoparticlesPolymersSpectrum AnalysisSurface Plasmon ResonanceSurface PropertiesAmino AcidsImmobilized Nucleic AcidsImmobilized ProteinsPolymersBiosensorBiosensorsNanocubesNanooctohedronNanosensorsNanotetrahedronOligonucleotidesSurface chemistryTriangular plates

Identifiers

PMID33506310
OpenAlexW3122566539

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.